Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omeros Corporation - Common Stock (NQ:OMER)

15.46 +6.71 (+76.69%)
Streaming Delayed Price Updated: 12:50 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,714,110
Open 16.44
Bid (Size) 15.44 (200)
Ask (Size) 15.47 (100)
Prev. Close 8.750
Today's Range 13.92 - 17.65
52wk Range 2.950 - 12.10
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Top movers in Wednesday's session ↗
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Which stocks are gapping on Wednesday? ↗
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill

Performance

YTD
+57.1%
+57.1%
1 Month
+58.4%
+58.4%
3 Month
+261.2%
+261.2%
6 Month
+357.4%
+357.4%
1 Year
+52.9%
+52.9%

More News

Read More
News headline image
Omeros Stock Jumps Premarket After FDA Approves First Drug For Rare Transplant Complication — Retail Sees Big Upside ↗
Via Stocktwits
News headline image
FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
From Omeros Corporation
Via Business Wire
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
Omeros Stock Garners High Retail Attention Ahead Of FDA Verdict For Life-Saving Drug ↗
Via Stocktwits
News headline image
Omeros Corp Sells Immune-System Drug To Novo Nordisk In $2.1B Deal — Retail Shifts Focus To Narsoplimab FDA Call ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
From Omeros Corporation
Via Business Wire
News headline image
Omeros (OMER) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Derivatives Earnings
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Omeros Corporation Reports Third Quarter 2025 Financial Results
From Omeros Corporation
Via Business Wire
News headline image
Examining the Future: Omeros's Earnings Outlook ↗
Via Benzinga
News headline image
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
From Omeros Corporation
Via Business Wire
News headline image
Breakout Momentum Plays You Need to Know About ↗
Via MarketBeat
News headline image
4 Biotech Stocks Lifting Off As Momentum Builds ↗
Via Benzinga
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings ↗
Via Benzinga
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group
From Omeros Corporation
Via Business Wire
News headline image
Satellogic, Hewlett Packard Enterprise, Bitfarms And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Why J.B. Hunt Transport Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now? ↗
Via The Motley Fool
News headline image
Omeros Stock Logs Best Session Ever After HC Wainwright Doubles Target On Novo Nordisk Deal; Retail Sees Big Upside ↗
Via Stocktwits

Frequently Asked Questions

Is Omeros Corporation - Common Stock publicly traded?
Yes, Omeros Corporation - Common Stock is publicly traded.
What exchange does Omeros Corporation - Common Stock trade on?
Omeros Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Omeros Corporation - Common Stock?
The ticker symbol for Omeros Corporation - Common Stock is OMER on the Nasdaq Stock Market
What is the current price of Omeros Corporation - Common Stock?
The current price of Omeros Corporation - Common Stock is 15.46
When was Omeros Corporation - Common Stock last traded?
The last trade of Omeros Corporation - Common Stock was at 12/24/25 12:50 PM ET
What is the market capitalization of Omeros Corporation - Common Stock?
The market capitalization of Omeros Corporation - Common Stock is 971.75M
How many shares of Omeros Corporation - Common Stock are outstanding?
Omeros Corporation - Common Stock has 972M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.